Target Audience

The initiative is intended for neurologists, physiatrists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and physical and occupational therapists

Improve your ability to identify muscle groups, explore treatment for spasticity and movement disorders, engage in multidisciplinary care, and participate in hands-on opportunities with two unique, profession-specific tracks.

TRACK 1 – US GUIDANCE AND TOXIN INJECTION PROCEDURES:

• Ultrasound guidance demonstrations and scanning workshops
• Injection training with models
• Toxin handling: dosing, dilution, draw-up, and beyond
• Patient injection demonstrations with ultrasound demonstrations
• Hands-on injection training

TRACK 2 – ANATOMY, COLLABORATIVE CARE, SPLINTING, AND CASTING:

• Functional and gross muscle anatomy, featuring cadaver videos
• Video case studies on post-chemodenervation therapy and individualizing care
• Video and hands-on demonstration of casting, splinting, and other techniques
• Patient injection demonstrations

Program Overview

The IMPACT™ Initiative Annual Workshop Series (IMproving Patient Assessment and Chemodenervation Treatment) will provide an interactive and comprehensive opportunity to improve your knowledge, confidence, and proficiency in essential aspects of spasticity and movement disorder management. This workshop aims to enhance patient outcomes from chemodenervation procedures by improving participants’ ability to recognize clinical patterns, identify muscle targets, and perform procedures confidently and skillfully, including using ultrasound guidance in these procedures.

This initiative will feature two specific tracks tailored to the unique educational needs of doctors/NPs/PAs and PTs/OTs. Our doctors/NP/PA track focuses on ultrasound use, injection demonstrations, and hands-one injection training. The PT/OT track will explore clinical and gross anatomy, considering implications for treatment utilizing cadaver videos, review chemodenervation principles, and feature video demonstrations of splinting and casting.

All participants will have the opportunity to explore strategies for multidisciplinary care and will participate in the expert-led patient injection demonstrations of ultrasound-guided chemodenervation procedures.

For full agenda and track-specific learning objectives, please visit www.impact-smd.com/agenda.

Disclosure

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Criteria for Success

Certificates of completion will be awarded based on the participant’s attendance and submission of the activity evaluation/claim credit form. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at tbrignoni@akhcme.com.

Credit provided by AKH Inc., Advancing Knowledge in Healthcare

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803.

This activity is approved for 8.0 contact hour(s) (which includes 0.0 hour(s) of pharmacology).

Nurses

8.0 ANCC contact hours

Occupational Therapy – credit applied for specific sessionPhysical Therapy – credit applied for specific session

location specificregistrations, Provider Information

This program is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC

Commercial Support

This activity is supported by educational grants from AbbVie Inc, Ipsen Biopharmaceuticals, Inc, and Merz Therapeutics

This activity is supported by in-kind support contributions from AbbVie Inc., Innovative RP Inc., Ipsen Biopharmaceuticals, Inc., Merz Therapeutics, and Terason.

Please see workshop registration pages for location specific support. 

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.